Immunohistochemistry and in situ hybridization (FISH)
- Technique
Many tumours look alike under the microscope; tagging one protein or gene inside the cells tells the pathologist what the tumour really is.
What it is
Immunohistochemistry (IHC) uses antibodies against a specific protein to locate it in a tissue section; the bound antibody is made visible with an enzyme that leaves a coloured deposit (often brown) or with a fluorescent dye. In situ hybridization (ISH) uses labelled nucleic acid probes that bind complementary DNA or RNA sequences; with fluorescent probes (FISH) it shows gene amplifications, deletions and translocations in individual nuclei. Both keep the tissue architecture, so the result is tied to the cells that carry it.
Key facts
- Cytokeratins mark epithelial cells: carcinoma versus lymphoma or melanoma.
- CD45 marks leukocytes; CD20 B cells and CD3 T cells classify lymphomas.
- S-100, SOX10 and melan-A mark melanocytic and neural crest cells (melanoma).
- Oestrogen receptor and HER2 in breast cancer guide targeted therapy; HER2 FISH settles an equivocal IHC.
- EBER ISH shows Epstein–Barr virus RNA in EBV-related lymphomas and nasopharyngeal carcinoma.
Step by step
- The section is deparaffinized and its antigens are unmasked, usually by heating.
- A primary antibody against the target protein is applied and binds it.
- Indirect method (the usual one): labelled secondary antibodies bind the primary, several per primary, amplifying the signal.
- An enzyme such as peroxidase turns a chromogen into a brown deposit where the antigen sits.
- Haematoxylin counterstain; the reader notes which cells stain and where (membrane, cytoplasm or nucleus).
- For FISH, DNA in the nuclei is denatured, a fluorescent probe binds its matching sequence and signals are counted per nucleus.
IHC versus in situ hybridization
| Feature | Immunohistochemistry (IHC) | In situ hybridization (ISH, FISH) |
|---|---|---|
| Target | A protein (antigen) | A DNA or RNA sequence |
| Probe | Antibody | Labelled complementary nucleic acid |
| Read-out | Coloured deposit (brown) or fluorescence | Fluorescent dots (FISH) or a coloured deposit (chromogenic ISH) |
| Question answered | Is the protein present, in which cells and where? | How many gene copies, is the gene broken or moved, is viral RNA present? |
| Classic use | HER2 protein, oestrogen receptor, lineage markers | HER2 amplification, BCR-ABL1 fusion, EBER (Epstein–Barr virus RNA) |
Clinical notes
- For a metastasis of unknown primary, a panel of IHC markers (for example CK7, CK20, TTF-1, CDX2) points to the likely site of origin.
- Ki-67 IHC estimates the fraction of dividing cells and helps grade tumours.
- FISH also detects translocations such as BCR::ABL1 in leukaemia and gene rearrangements in some sarcomas and lymphomas.
- Mismatch-repair protein IHC screens colorectal and endometrial cancers for Lynch syndrome.
Common traps
- A brown IHC stain means the cell is malignant: it only shows the protein is present; benign cells express most markers, so the pattern decides, not the colour.
- A positive cytokeratin tells you which organ the tumour came from: it shows epithelial origin only; the site comes from a panel such as CK7, CK20, TTF-1 and CDX2.
- HER2 IHC and HER2 FISH measure the same thing: IHC sees the protein on the membrane and FISH counts gene copies, which is why FISH resolves an equivocal IHC.
- Where the stain sits in the cell does not matter: a nuclear marker such as oestrogen receptor or Ki-67 must stain the nucleus, so location is part of the result.
Test yourself
Think of the answer, then tap the question to see it.
A poorly differentiated tumour in a lymph node is cytokeratin-negative and CD45-positive. What is it most likely, and why?
A lymphoma: CD45 marks leukocytes, and the absence of cytokeratin argues against carcinoma.
Why is the indirect IHC method more sensitive than the direct method?
Several labelled secondary antibodies bind each primary antibody, so each antigen collects more label.
HER2 IHC on a breast cancer is equivocal. What test comes next, and what does it measure?
HER2 FISH, which counts HER2 gene copies per nucleus to decide whether the gene is amplified.
Why does IHC show which cells express a protein when a test on ground-up tissue cannot?
The section keeps the architecture, so the stain lands on particular cells and compartments; an extract mixes all cells together.
Connections
Educational content on normal microscopic structure and its clinical relevance; no substitute for studying slides or for a health professional's advice.
Sources: HER2 Tumor Marker Test: MedlinePlus Medical Test (MedlinePlus, US National Library of Medicine, 2025); Pathology Reports (National Cancer Institute, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
